0001767398-23-000001.txt : 20230811 0001767398-23-000001.hdr.sgml : 20230811 20230811095041 ACCESSION NUMBER: 0001767398-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 EFFECTIVENESS DATE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Melt Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001767398 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611888986 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489452 FILM NUMBER: 231161903 BUSINESS ADDRESS: STREET 1: 6 CADILLAC DRIVE STREET 2: SUITE 320 CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 8587044042 MAIL ADDRESS: STREET 1: 6 CADILLAC DRIVE STREET 2: SUITE 320 CITY: BRENTWOOD STATE: TN ZIP: 37027 D 1 primary_doc.xml X0708 D LIVE 0001767398 Melt Pharmaceuticals, Inc. 6 CADILLAC DRIVE SUITE 320 BRENTWOOD TN TENNESSEE 37027 629-802-9555 DELAWARE None None Corporation true 2019 Larry Dillaha 6 Cadillac Drive Suite 320 Brentwood TN TENNESSEE 37027 Executive Officer Brad Osborne 6 Cadillac Drive Suite 320 Brentwood TN TENNESSEE 37027 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2023-07-28 false true false 0 Newbridge Securities Corporation None None None 1200 North Federal Highway Suite 400 Boca Raton FL FLORIDA 33432 DE DELAWARE false 30000000 1808970 28191030 false 37 135672 0 0 true false Melt Pharmaceuticals, Inc. /s/ Brad Osborne Brad Osborne Chief Financial Officer 2023-08-11